Pitcairn Islands - Press Releases

  • 4362 Press Releases ยท
  • RSS
Published on Fri 21 Feb 2025 10:35:02 UTC
SAN DIEGO, Feb. 20, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant and/or traceable to Neumora's registration statement issued in connection with Neumora's initial public offering (the "IPO") held on September 15, 2023, have until April 7, 2025 to seek appointment as lead plaintiff of the Neumora class action lawsuit. Captioned Chang v. Neumora Therapeutics, Inc., No. 25-cv-01072, and pending it the Southern District of New York, the Neumora class action lawsuit charges Neumora as well as certain of Neumora's top executives and directors, and certain underwriters of the IPO, with violations of the Securities Act of 1933.
Published on Fri 21 Feb 2025 10:34:59 UTC
BROOKLYN, N.Y., Feb. 20, 2025 /PRNewswire/ -- On or about September 19, 2024, Atlantis Operating LLC d/b/a The Phoenix Rehabilitation and Nursing Center ('Phoenix') learned of a data security incident involving a third party vendor, which may have impacted the personal information of current and/or past patients of Phoenix. Phoenix has since diligently worked to determine what happened and what information was involved as a result of this incident. Phoenix, consistent with industry standards, promptly launched an investigation and engaged experts to assist in assessing the scope of the incident. Based on information provided by the third party, it was determined the incident occurred between on or about July 20, 2024. Upon identification of the potentially impacted data set, efforts were then initiated to provide notice to the potentially impacted population.
Published on Fri 21 Feb 2025 10:34:57 UTC
Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia
Published on Fri 21 Feb 2025 10:34:56 UTC
The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely fueled by the increasing uptake of the influenza vaccine and government efforts to raise awareness and encourage vaccination.
Published on Fri 21 Feb 2025 10:34:52 UTC
Enhanced Women's Health Program Integrates Pelvic Floor Therapy and Menopause Care Through Partnership with Vira Health
Published on Fri 21 Feb 2025 10:34:48 UTC
FREMONT, Calif., Feb. 20, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified Service Provider (CSP) Program, designed to expand access to its cutting-edge NULISA assays in academia and biopharmaceutical research.
Published on Fri 21 Feb 2025 10:34:45 UTC
WINDHAM, N.H., Feb. 20, 2025 /PRNewswire/ --The United States is projected to face a shortage of up to 8,650 cardiologists by 2037, raising serious concerns about access to cardiovascular care. To help healthcare leaders navigate the growing workforce challenge, Medicus Healthcare Solutions has released a new white paper titled An Inside Look at the Cardiology Workforce: Shortages, Demand, and Strategic Responses.
Published on Fri 21 Feb 2025 10:34:39 UTC
HONG KONG, Feb. 20, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in itsmulticenter, randomized, double-blind Phase III clinical trial of ivonescimab in combination with chemotherapy for first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) (HARMONi-BC1/AK112-308). Ivonescimab is a first-in-class PD-1/VEGF bispecific antibody independently developed by the company.
Published on Fri 21 Feb 2025 10:34:38 UTC
Auf dem 25. Wellness Congress stellte Nerio Alessandri in Anwesenheit von 2.000 Menschen aus 100 Lndern Healthness vor, die neue Vision, die die Zukunft von Wellness und Prvention revolutionieren wird.
Published on Fri 21 Feb 2025 10:34:07 UTC
LUND,Sweden, Feb. 21, 2025 /PRNewswire/ --Immunovia will publish its full year 2024 results on February 25, 2025 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com.
Published on Fri 21 Feb 2025 10:34:02 UTC
SEGUIN, Texas, Feb. 20, 2025 /PRNewswire/ -- Alamo Group Inc. (NYSE: ALG) today announced that it will release its fourth quarter and year-end financial results after the market closes on Thursday, February 27, 2025. The Company will host a conference call to discuss the results on Friday, February 28, 2025, at 10:00 a.m. ET. Hosting the call will be members of senior management.
Published on Fri 21 Feb 2025 10:33:45 UTC
Teamsters Demand Employer Negotiate in Good Faith for Fair First Contract
Published on Fri 21 Feb 2025 10:33:34 UTC
Kenwood Investments to Build Bay Area's First New Bay Area Marina in Nearly 25 Years After Winning BCDC Approval
Published on Fri 21 Feb 2025 10:33:33 UTC
Three builders launched home sales, selling 13 homes in one month, and construction has started on more than half the homes in Phase 1.
Published on Fri 21 Feb 2025 10:33:20 UTC
LANCASTER, Pa., Feb. 20, 2025 /PRNewswire/ -- Burnham Holdings, Inc. (OTC-Pink: BURCA) ("BHI", the "Company", "we" or "our") today reported its consolidated financial results for the fourth quarter and full year of 2024, setting new all-time highs in net sales, net income and earnings per share. Where noted, prior periods presented have been restated for a voluntary change in accounting principle related to our last-in, first-out (LIFO) inventory valuation as disclosed in our 2023 Annual Report.
Published on Fri 21 Feb 2025 10:33:14 UTC
DSSELDORF, Germany, Feb. 21, 2025 /PRNewswire/ -- TK Elevator (TKE), a global leader in vertical transportation and urban mobility, has secured orders for a total of 185 elevator units with two strategic collaborations in Egypt's New Administrative Capital. This includes a milestone contract win with a returning customer, the National Bank of Kuwait (NBK), and a new customer win with Misr Italia Properties for its luxury boutique development, Vinci -COMO Lakes. These project wins underscore TKE's reputation for supporting customer success through urban renewal and expansion with innovative mobility solutions that are essential for future urban life.
Published on Fri 21 Feb 2025 10:33:11 UTC
Prepares the way for entry into service
Published on Fri 21 Feb 2025 10:32:50 UTC
Bracco will present an immersive experience at its booth to educate congress attendees on the importance of corporate commitment to sustainability and how its MR imaging portfolio contributes to the progress of sustainable radiology.
Published on Fri 21 Feb 2025 10:32:42 UTC
Bracco Diagnostics Inc. (PRNewsFoto/Bracco Diagnostics Inc.) (PRNewsfoto/Bracco Group)
Published on Fri 21 Feb 2025 10:31:48 UTC
STOCKHOLM, Feb. 21, 2025 /PRNewswire/ -- SciBase Holding AB("SciBase") (STO: SCIB),a leading developer of augmented intelligence-based solutions for skin disordersannounced today, that an article comparing US and German dermatologists improved biopsy decisions following the addition of Nevisense (EIS) as a decision support tool was recently published in SKIN, the Journal of Cutaneous Medicine. The article compares two corresponding studies, one conducted in the US and one in Germany, with the aim to evaluate how Nevisense (EIS) impacted dermatologist's biopsy decisions. The findings were that for both groups the addition of dermoscopy and even more so Nevisense (EIS) as decision support tools significantly improved biopsy decision accuracy. Findings revealed that American dermatologists had a higher rate of correct biopsy decisions for malignant melanomas (MMs) compared to their German counterparts. However, German dermatologists showed greater accuracy in avoiding unnecessary biopsies of benign pigmented skin lesions.
Published on Fri 21 Feb 2025 10:31:07 UTC
HELLERUP,Denmark, Feb. 21, 2025 /PRNewswire/ -- UNION therapeutics A/S (UNION), a privately-held, clinical stage, pharmaceutical development company focused on immunology, today announced a poster presentation on new clinical data of oral orismilast in patients with UC at the 20thEuropean Crohn's and Colitis Organisation (ECCO) congress on February 19-22, 2025, in Berlin, Germany.
Published on Fri 21 Feb 2025 10:31:06 UTC
HELLERUP,Denmark, Feb. 21, 2025 /PRNewswire/ -- UNION therapeutics A/S (UNION), a privately-held, clinical stage, pharmaceutical development company focused on immunology, today announced a poster presentation on new clinical data of oral orismilast in patients with UC at the 20thEuropean Crohn's and Colitis Organisation (ECCO) congress on February 19-22, 2025, in Berlin, Germany.
Published on Fri 21 Feb 2025 10:31:04 UTC
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIV.sdb), the worldwide leader in automotive safety systems, has filed with the Securities and Exchange Commission (SEC) its 2024 Annual Report on Form 10-K as well its annual sustainability report, filed together with the 10-K as an Annual Report to Shareholders (ARS).
Published on Fri 21 Feb 2025 10:31:03 UTC
PITTSBURGH, Feb. 20, 2025 /PRNewswire/ -- TMS International Corporation proudly announces the appointment of Joel Hawthorne as its new President and Chief Executive Officer, effective March 3, 2025.
Published on Fri 21 Feb 2025 10:30:59 UTC
Digitln rozvodna 220 kV Zafarabd v provincii Dizch, kterou dodala spolenost Shanghai Electric, pedstavuje vznamn milnk v jejm zvazku zkvalitovat energetickou infrastrukturu a podporovat digitln transformaci v energetickm sektoru